Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q2 FY23 results · Jul–Sep 2022

Advanced Enzyme Technologies reported revenue from operations of ₹138.69 crore (up 9.1% from Q2 FY22) and net profit of ₹26.26 crore (down 13.2% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY23Q2 FY22YoYQ1 FY23QoQ
Revenue from operations138.69127.08+9.1%121.12+14.5%
Other income3.870.90+330.5%1.99+94.1%
Total income142.56127.98+11.4%123.12+15.8%
Profit before tax34.1441.24−17.2%23.70+44.1%
Net profit for the period26.2630.27−13.2%17.58+49.4%
Attributable to shareholders of the company26.21——17.87+46.6%
EPS, basic (₹)2.342.66−12.0%1.60+46.2%
Net margin (%)18.923.814.5
Standalone · ₹ crore
ItemQ2 FY23Q2 FY22YoYQ1 FY23QoQ
Revenue from operations77.1864.91+18.9%72.11+7.0%
Other income2.001.90+5.2%1.25+60.6%
Total income79.1866.81+18.5%73.36+7.9%
Profit before tax18.4117.25+6.8%10.28+79.2%
Net profit for the period13.6212.84+6.0%7.78+75.1%
EPS, basic (₹)1.221.15not comparable0.70+74.3%
Net margin (%)17.619.810.8
Consolidated
Filed with BSE
12 Nov 2022, 16:57 IST
Board meeting
11 Nov 2022
Period
01 Jul 2022 to 30 Sep 2022
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
12 Nov 2022, 16:57 IST
Board meeting
11 Nov 2022
Period
01 Jul 2022 to 30 Sep 2022
Review status
Unaudited
Source
XBRL filing on BSE